•   
  •   

UK News COVID-19. A PFIZER vaccine targeting two omicron subvariants could soon be approved

17:20  10 august  2022
17:20  10 august  2022 Source:   ouest-france.fr

'Living with COVID': Where the pandemic could go next

  'Living with COVID': Where the pandemic could go next 'Living with COVID': Where the pandemic could go nextLONDON/CHICAGO (Reuters) - As the third winter of the coronavirus pandemic looms in the northern hemisphere, scientists are warning weary governments and populations alike to brace for more waves of COVID-19.

Un flacon de vaccin contre le Covid-19 du laboratoire Pfizer. © Dado Ruvic / Reuters A Vaccine Vaccine bottle of the PFIZER laboratory.

An anti-Cavid vaccine targeting several omicron subvariants could be approved in the fall by the European Medicines Agency, according to an announcement made on Wednesday August 10, 2022.

The European Medicines Agency (EMA) could Approve an anti-Cavid vaccine from Pfizer/BionTech to approve from the fall of the fall of the Omicron Sub-Variants for rapid propagation, said a spokesperson for the regulator on Wednesday, August 10, 2022.

The Sublicks of Omicron BA.4 and BA.5 fuel an increase in COVID-19 cases in Europe and the United States, which prompted WHO to declare last month that the pandemic was " Far from being finished ”.

On-screen couples with zero chemistry

  On-screen couples with zero chemistry The actress is set to play Elle Woods in the third instalment of Legally Blonde, which is currently slated for a release in 2023, 22 years after the first film and 19 years after the 2003 sequel, Legally Blonde 2: Red, White & Blonde. During an interview with USA Today, Reese explained the third film's team have taken inspiration from how Top Gun: Maverick - which was released 36 years after its predecessor hit certain nostalgic beats to please fans while feeling like a fresh and exciting story.

The European regulator said it launched an examination of an appropriate version of the Pfizer anti-Cavid serum targeting these two subvariants, more easily transmitted on Monday, which escape the immune system than previous strains.

A suitable BA.4/5

vaccine "EMA expects to receive a request for the suitable vaccine BA.4/5 developed by Pfizer/BionTech , which will be evaluated for potential rapid approval in autumn ", said a spokesperson.

This should happen "Shortly after" The expected approval of two other vaccines adapted by Pfizer and its Moderna rival, which target the original covid-19 strain and the anterior subvariant BA.1 of omicron, a said the spokesperson.

PFIZER and MODERNA had applied for separate approval for these vaccines on July 22, the spokesman said.

EMA previously said that the first Omicron targeting serums could be approved in September.

COVID jab targeting both original strain and Omicron to be rolled out from 5 September .
A COVID jab which targets both the original strain and Omicron will be rolled out across England from 5 September as part of the autumn booster programme. © Sky News Screen Grab Care home residents and people who are housebound will be among the first to be jabbed when the rollout gets underway, NHS England has said.A wider rollout is due to begin on 12 September.The UK became the first country in the world on Monday to approve Moderna's vaccine which targets both the original strain of COVID and the Omicron variant.

usr: 0
This is interesting!